Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.33 |
| ▸ | UGCG | Q16739 | 6/20 | 0.33 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10136610 | 0.91 | DHODH (0.33) | TACR1CYP3A4UGCGDHODH | |
| SCHEMBL10136641 | 0.90 | ALDH1A1 (0.34) | TACR1CYP3A4UGCGCAPN1PSMB5 | |
| SCHEMBL10136623 | 0.89 | DHODH (0.35) | TACR1CYP3A4UGCGCAPN1PSMB5 | |
| SCHEMBL10136217 | 0.85 | GRM4 (0.36) | CAPN1DHODHCCR1ALDH1A1 | |
| SCHEMBL10118322 | 0.84 | ALDH1A1 (0.35) | DHODHALDH1A1 | |
| SCHEMBL10136642 | 0.84 | ALDH1A1 (0.35) | CYP3A4UGCGCAPN1DHODHALDH1A1 | |
| SCHEMBL10136315 | 0.82 | MDM2 (0.32) | TACR1CYP3A4UGCGDHODH | |
| SCHEMBL10136639 | 0.82 | SLC2A1 (0.34) | TACR1DHODH | |
| SCHEMBL10136612 | 0.82 | ALDH1A1 (0.35) | CYP3A4UGCGDHODHALDH1A1 | |
| SCHEMBL10118273 | 0.82 | NPY5R (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582688-B1 | ANTHRANILIC ACID DIAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | TACR1 591/4885CYP3A4 1009/4885UGCG 3113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.